- Home
- KLTOW vs LZM Comparison
KLTOW vs LZM Comparison
Compare KLTOW & LZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTOW
- LZM
- Stock Information
- Founded
- KLTOW N/A
- LZM 2021
- Country
- KLTOW United States
- LZM Isle of Man
- Employees
- KLTOW 3
- LZM N/A
- Industry
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- LZM Metal Mining
- Sector
- KLTOW Health Care
- LZM Basic Materials
- Exchange
- KLTOW Nasdaq
- LZM Nasdaq
- Market Cap
- KLTOW N/A
- LZM N/A
- IPO Year
- KLTOW 2022
- LZM N/A
- Fundamental
- Price
- KLTOW $0.25
- LZM $4.25
- Analyst Decision
- KLTOW
- LZM Strong Buy
- Analyst Count
- KLTOW 0
- LZM 1
- Target Price
- KLTOW N/A
- LZM $14.00
- AVG Volume (30 Days)
- KLTOW N/A
- LZM 175.8K
- Earning Date
- KLTOW N/A
- LZM 08-18-2025
- Dividend Yield
- KLTOW N/A
- LZM N/A
- EPS Growth
- KLTOW N/A
- LZM N/A
- EPS
- KLTOW N/A
- LZM N/A
- Revenue
- KLTOW N/A
- LZM $140,522.00
- Revenue This Year
- KLTOW N/A
- LZM $611.56
- Revenue Next Year
- KLTOW N/A
- LZM $344.44
- P/E Ratio
- KLTOW N/A
- LZM N/A
- Revenue Growth
- KLTOW N/A
- LZM N/A
- 52 Week Low
- KLTOW N/A
- LZM $2.90
- 52 Week High
- KLTOW N/A
- LZM $9.30
- Technical
- Relative Strength Index (RSI)
- KLTOW N/A
- LZM 50.00
- Support Level
- KLTOW N/A
- LZM $4.29
- Resistance Level
- KLTOW N/A
- LZM $4.72
- Average True Range (ATR)
- KLTOW 0.00
- LZM 0.29
- MACD
- KLTOW 0.00
- LZM -0.03
- Stochastic Oscillator
- KLTOW 0.00
- LZM 28.21
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.